Buspirone for Management of Dyspnea in Cancer Patients Receiving Chemotherapy: A Randomized Placebo-Controlled URCC CCOP Study

PURPOSE: Cancer-related dyspnea is a common, distressing, and difficult to manage symptom in cancer patients, resulting in diminished quality of life and poor prognosis. Buspirone, a nonbenzodiazepine anxiolytic which does not suppress respiration and has proven efficacy in the treatment of generali...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Support Care Cancer
Main Authors: Peoples, Anita R., Bushunow, Peter W., Garland, Sheila N., Heckler, Charles E., Roscoe, Joseph A., Peppone, Luke L., Dudgeon, Deborah J., Kirshner, Jeffrey J., Banerjee, Tarit K., Hopkins, Judith O., Dakhil, Shaker R., Flannery, Marie A., Morrow, Gary R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4731275/
https://ncbi.nlm.nih.gov/pubmed/26329396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-015-2903-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados